U.S. Markets closed

AstraZeneca PLC (AZN)


NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
34.05+0.16 (+0.47%)
At close: 4:02PM EDT
People also watch
GSKNVSSNYLLYBMY
Full screen
Previous Close33.89
Open34.00
Bid0.00 x
Ask0.00 x
Day's Range33.88 - 34.07
52 Week Range25.55 - 35.60
Volume3,602,670
Avg. Volume4,408,368
Market Cap84.42B
Beta0.72
PE Ratio (TTM)25.51
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield1.90 (5.58%)
Ex-Dividend Date2017-02-15
1y Target EstN/A
Trade prices are not sourced from all markets
  • Biotechs On A Hot Streak, And Could Be 'Cooking With Gas'
    Investor's Business Daily2 days ago

    Biotechs On A Hot Streak, And Could Be 'Cooking With Gas'

    IBD's 439-company Biotech industry group is now ranked fourth out of 197. How far can the rally go?

  • Pharma Stock Roundup: J&J, NVS' Q2 Earnings, Merck Drug Gets Tentative FDA Nod
    Zacks2 days ago

    Pharma Stock Roundup: J&J, NVS' Q2 Earnings, Merck Drug Gets Tentative FDA Nod

    Pharma sector second quarter earnings season has started with industry bellwether Johnson & Johnson (JNJ) reporting earlier this week while AstraZeneca and Merck provided regulatory updates.

  • Reuters3 days ago

    AstraZeneca CEO reassures staff, aims to be at September cancer meet

    AstraZeneca Chief Executive Pascal Soriot, responding to rumors he might leave the drugmaker to join rival Teva Pharmaceutical Industries, has told staff he expects to work "together" with employees to see the company succeed. A company spokeswoman added he was intending to attend the European Society for Medical Oncology annual meeting in Madrid in September, assuming that AstraZeneca had clinical data on its new immunotherapy medicine ready to present at the event. Soriot did not comment on whether he had received a job offer from Teva in the internal memo to staff, which was sent out at the start of this week.